tDCS for Dysphagia Associated to Brainstem Stroke
Primary Purpose
Dysphagia
Status
Unknown status
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Anodal tDCS
Sponsored by
About this trial
This is an interventional treatment trial for Dysphagia
Eligibility Criteria
Inclusion Criteria:
- accepting to participating to the study
- age not < 18 years
- bulbar stroke occurring within the previous 24 hours
Exclusion Criteria:
- age < 18 years
- inability to give informed consent because of cognitive impairment
- stroke occurring over the previous 24 hours
Sites / Locations
- Domenico A. RestivoRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Sham Comparator
Arm Label
real tDCS
sham tDCS
Arm Description
30 patients will be treated with real anodal tDCS over the contralateral pharyngeal motor cortex
30 patients will be treated with sham tDCS over the contralateral pharyngeal motor cortex
Outcomes
Primary Outcome Measures
Penetration Aspiration Scale (PAS)
PAS is an 8-point severity scale from 1 = no material enters the airways to 8 = material enters the airways, passes below the vocal folds in the absence of any effort to eject it.
Secondary Outcome Measures
Functional Oral Intake Scale (FOIS)
FOIS is a scale ranging from 1 (nothing by mouth) to 7 (total oral diet with no restriction)
Dysphagia Limit Test
The "Dysphagia Limit Test", evaluates the amount of water that can be swallowed without piece-meal deglutition or clinical signs of aspiration.
Pharyngeal (motor evoked potentials (MEPs) after Transcranial Magnetic Stimulation (TMS)
the changes in amplitude of MEPs recorded from pharyngeal muscle after TMS over the pharyngeal contralateral motor cortex will be evaluated
electromyographic/cinematic evaluation of swallowing
Simultaneous electromyographic/cinematic recordings from mouth floor muscles, cricopharyngeal muscle and thyroid cartilage will be performed
Full Information
NCT ID
NCT04308733
First Posted
March 8, 2020
Last Updated
September 14, 2020
Sponsor
Presidio Ospedaliero Garibaldi-Centro
1. Study Identification
Unique Protocol Identification Number
NCT04308733
Brief Title
tDCS for Dysphagia Associated to Brainstem Stroke
Official Title
Transcranial Direct Current Stimulation (tDCS) for Patients With Oro-pharyngeal Dysphagia Associated to Brainstem Stroke
Study Type
Interventional
2. Study Status
Record Verification Date
September 2020
Overall Recruitment Status
Unknown status
Study Start Date
March 30, 2020 (Actual)
Primary Completion Date
March 30, 2021 (Anticipated)
Study Completion Date
March 30, 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Presidio Ospedaliero Garibaldi-Centro
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The aim of the study is to investigate the effect of anodal transcranial direct current stimulation applied over the pharyngeal motor area in 60 dysphagic patients with acute isolated brainstem stroke. Thirty patients will undergo stimulation on the pharyngeal area contralateral to the side of brainstem lesion, and 30 patients will receive sham stimulation over the contralateral area, for 4 consecutive days. Patients will be re-evaluated after 4 consecutive days of stimulation. Primary outcome: The Penetration/Aspiration Scale after 4 consecutive days of stimulation. Secondary outcomes: changes in electromyographic parameters and pharyngeal cortical motor evoked potentials, changes in the Dysphagia Severity Rating Scale (DSRS), in the Functional Oral Intake Scale (FOIS), and in the "Dysphagia Limit Test", after 4 consecutive days of stimulation.
Detailed Description
Sixty consecutive patients with dysphagia associated to isolated acute (within the previous 24 hours) brainstem ischemic stroke satisfying the inclusion/exclusion criteria will be enrolled.
Swallowing evaluation Clinical evaluation comprises fiberoptic endoscopy that will be used for scoring the Penetration/Aspiration Scale. The Penetration/Aspiration Scale will be scored by two otolaryngologists and one neurologist blinded to the patient's study group allocation. Moreover, feeding status will be evaluated by the clinical "Dysphagia Severity Rating Scale", ranging from 0 (normal fluids, normal diet, and eating independently) to 12 (no oral fluids, no oral feeding). Moreover the "Functional Oral Intake Scale", ranging from 1 (nothing by mouth) to 7 (total oral diet with no restriction), and the "Dysphagia Limit Test", evaluating the amount of water that can be swallowed without piece-meal deglutition or clinical signs of aspiration, will be used in patient evaluation. Piecemeal deglutition will be evaluated both clinically and by means of electromyographic recordings from the mouth floor muscles. Moreover, simultaneous electromyographic/mechanographic recordings from the above mentioned muscles, as well as from cricopharyngeal muscle and from the thyroid cartilage will be also performed. The changes in cortico-pharyngeal excitability will be evaluated by recording motor evoked potentials from the pharyngeal muscles after transcranial magnetic stimulation.
Randomization: patients will be randomly assigned to either the active treatment (real) or sham groups according to a computer-generated list. Randomization will be stratified in order to match age, and severity of dysphagia.
Transcranial direct current stimulation: anodal transcranial direct current stimulation will be delivered through two 25-cm2 rectangular surface electrodes, with the active one placed over the "pharyngeal" area of the motor cortex contralateral to the side of brainstem lesion and the reference one on the contralateral supraorbital ridge. Furthermore, the electrodes will be fixed in their position using a set of adjustable rubber straps placed around the head. For the active intervention (the "real" stimulation group), current intensity will be slowly increased up to 2mA. This intensity will be maintained for 20 min before the stimulation will be slowly turned off over a 10-sec period. For the "sham" intervention, the current will be left on only for 30 sec, while the electrodes will be left in place for a further 20-min period. All patients will be evaluated at baseline, and after 4 consecutive days of stimulation.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dysphagia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Masking Description
double-blind
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
real tDCS
Arm Type
Active Comparator
Arm Description
30 patients will be treated with real anodal tDCS over the contralateral pharyngeal motor cortex
Arm Title
sham tDCS
Arm Type
Sham Comparator
Arm Description
30 patients will be treated with sham tDCS over the contralateral pharyngeal motor cortex
Intervention Type
Device
Intervention Name(s)
Anodal tDCS
Intervention Description
patients will be stimulated over the contralateral pharyngeal motor cortex with anodal tDCS (2mA, 20 minutes) for 4 consecutive days
Primary Outcome Measure Information:
Title
Penetration Aspiration Scale (PAS)
Description
PAS is an 8-point severity scale from 1 = no material enters the airways to 8 = material enters the airways, passes below the vocal folds in the absence of any effort to eject it.
Time Frame
Change from baseline PAS at 4 days
Secondary Outcome Measure Information:
Title
Functional Oral Intake Scale (FOIS)
Description
FOIS is a scale ranging from 1 (nothing by mouth) to 7 (total oral diet with no restriction)
Time Frame
Change from baseline FOIS at 4 days
Title
Dysphagia Limit Test
Description
The "Dysphagia Limit Test", evaluates the amount of water that can be swallowed without piece-meal deglutition or clinical signs of aspiration.
Time Frame
Change from baseline "Dysphagia Limit Test" at 4 days
Title
Pharyngeal (motor evoked potentials (MEPs) after Transcranial Magnetic Stimulation (TMS)
Description
the changes in amplitude of MEPs recorded from pharyngeal muscle after TMS over the pharyngeal contralateral motor cortex will be evaluated
Time Frame
Change from baseline pharyngeal MEPs at 4 days
Title
electromyographic/cinematic evaluation of swallowing
Description
Simultaneous electromyographic/cinematic recordings from mouth floor muscles, cricopharyngeal muscle and thyroid cartilage will be performed
Time Frame
Change from baseline electromyographic/cinematic parameters at 4 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
accepting to participating to the study
age not < 18 years
bulbar stroke occurring within the previous 24 hours
Exclusion Criteria:
age < 18 years
inability to give informed consent because of cognitive impairment
stroke occurring over the previous 24 hours
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Domenico A Restivo, MD, PhD
Phone
+39 095 7593909
Email
darestivo@libero.it
Facility Information:
Facility Name
Domenico A. Restivo
City
Catania
ZIP/Postal Code
95100
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Domenico A Restivo, MD, PhD
Phone
+39 095 7593909
Email
darestivo@libero.it
12. IPD Sharing Statement
Learn more about this trial
tDCS for Dysphagia Associated to Brainstem Stroke
We'll reach out to this number within 24 hrs